Abbott (ABT) ended the recent trading session at $114.12, demonstrating a -1.92% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.04%. Meanwhile, the Dow ...

Abbott Laboratories (NYSE:ABT) is scheduled to announce its second-quarter earnings on Thursday, July 17, 2025. For traders who focus on events, examining the historical reactions of the stock to ...

Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1.34 ...

Recent performance snapshot Abbott Laboratories (ABT) has seen mixed share performance recently, with a modest 0.2% move over ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Investors in Abbott Laboratories (Symbol: ABT) saw new options begin trading today, for the August 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

Robert B Ford, the CHAIRMAN AND CEO of $ABT, sold 285,388 shares of the company on 02-05-2025 for an estimated $37,435,200. We received data on the trade from a ...

Abbott Laboratories (NYSE: ABT) will release its fiscal fourth-quarter earnings report next Thursday before the opening bell, setting up an intriguing idea for bullish options traders. Ordinarily, ABT ...